MedPath

The University Of Texas Health Science Center At San Antonio

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Rapamycin - Effects on Alzheimer's and Cognitive Health

Phase 2
Recruiting
Conditions
Alzheimer Disease
Mild Cognitive Impairment
Interventions
Other: Placebo
Drug: Rapamycin
First Posted Date
2020-11-16
Last Posted Date
2024-08-13
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
40
Registration Number
NCT04629495
Locations
🇺🇸

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio, Texas, United States

Retention of Nasoenteric Feeding Tubes in Pediatric Patients Using a Nasal Bridle

Not Applicable
Completed
Conditions
Feeding Tube Complication
Interventions
Device: AMT BridlePro Device
Device: Adhesive Tape
First Posted Date
2020-11-09
Last Posted Date
2023-08-14
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
35
Registration Number
NCT04621734
Locations
🇺🇸

University Health System, San Antonio, Texas, United States

Genetic Investigation of Cancer Predisposition

Not yet recruiting
Conditions
Cancer
Genetic Predisposition
First Posted Date
2020-11-06
Last Posted Date
2024-12-13
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
100
Registration Number
NCT04620278
Locations
🇺🇸

University of Texas Health Science Center, San Antonio, Texas, United States

Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock

Early Phase 1
Completed
Conditions
Aging
Epigenetics
Inflammatory Mediators
Interventions
Drug: Rapamycin Topical Ointment
Other: Placebo
First Posted Date
2020-10-29
Last Posted Date
2023-07-19
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
22
Registration Number
NCT04608448
Locations
🇺🇸

UTHSCSA, San Antonio, Texas, United States

Confirming Feeding Tube Position Using CORTRAK

Not Applicable
Withdrawn
Conditions
Enteral Nutrition
Interventions
Device: CORTRAK Stylet
First Posted Date
2020-10-23
Last Posted Date
2024-05-08
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Registration Number
NCT04601571
Locations
🇺🇸

University Health Systems Hospital, San Antonio, Texas, United States

Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer

Recruiting
Conditions
Gastric Cancer
Interventions
Other: Molecular testing for all participants.
Other: Germline Testing
Other: Survey
First Posted Date
2020-10-23
Last Posted Date
2024-02-22
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
150
Registration Number
NCT04600466
Locations
🇺🇸

Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States

Trial of Nano-hydroxyapatite-Containing Toothpastes for Relief of Dentin Hypersensitivity

Not Applicable
Completed
Conditions
Dentin Sensitivity
Interventions
Device: 5% KNO3 toothpaste
Other: Placebo
Device: 15% nano-HAP toothpaste
First Posted Date
2020-10-19
Last Posted Date
2023-08-16
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
192
Registration Number
NCT04590040
Locations
🇺🇸

School of Dentistry, University of Texas Health Science Center, San Antonio, Texas, United States

Reducing the Abuse Liability of Prescription Opioids

Early Phase 1
Completed
Conditions
Addiction
Interventions
First Posted Date
2020-10-14
Last Posted Date
2020-10-14
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
15
Registration Number
NCT04587115
Locations
🇺🇸

Westgate Pain Clinic, San Antonio, Texas, United States

Sacituzumab Govitecan in Recurrent Glioblastoma

Phase 2
Recruiting
Conditions
Glioblastoma
Interventions
First Posted Date
2020-09-22
Last Posted Date
2024-03-13
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
40
Registration Number
NCT04559230
Locations
🇺🇸

University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio, Texas, United States

🇺🇸

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

🇺🇸

Texas Oncology, Dallas, Texas, United States

Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease

Phase 1
Completed
Conditions
Alzheimer Disease, Early Onset
Interventions
First Posted Date
2020-09-17
Last Posted Date
2024-08-09
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
12
Registration Number
NCT04552795
Locations
🇺🇸

Sam and Ann Barshop Institute for Longevity & Aging Studies, San Antonio, Texas, United States

🇺🇸

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio, Texas, United States

🇺🇸

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath